Mental Disorders and Quality of Life in Patients With Pulmonary Arterial Hypertension Treated With Sotatercept
ABSTRACT Sotatercept has recently expanded treatment options for pulmonary arterial hypertension (PAH), but its mental health and quality‐of‐life impact is not well characterized. We assessed psychiatric diagnoses and patient‐reported outcomes in PAH patients treated with sotatercept within the clin...
Gespeichert in:
| Hauptverfasser: | , , , , , , , , |
|---|---|
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
Wiley
2026-04-01
|
| Schriftenreihe: | Pulmonary Circulation |
| Schlagworte: | |
| Online-Zugang: | https://doi.org/10.1002/pul2.70324 |
| Tags: |
Keine Tags, Fügen Sie das erste Tag hinzu!
|
